Cargando…
Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD
Clinical manifestations of chronic obstructive pulmonary disease (COPD), including airflow limitation, dyspnea, and activity limitation, ultimately lead to impaired health-related quality of life (HRQoL). This 9-month, randomized, double-blind, multicenter study compared the effect of once-daily tio...
Autores principales: | Tonnel, A-B, Perez, T, Grosbois, J-M, Verkindre, C, Bravo, M-L, Brun, M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2629970/ https://www.ncbi.nlm.nih.gov/pubmed/18686739 |
Ejemplares similares
-
Validity, reliability, and responsiveness of a new shortVisual Simplified Respiratory Questionnaire (VSRQ(©)) for health-related quality of life assessment in chronic obstructive pulmonary disease
por: Perez, T, et al.
Publicado: (2009) -
Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
por: Koehorst-ter Huurne, Kirsten, et al.
Publicado: (2016) -
Role of tiotropium in the treatment of COPD
por: Rice, Kathryn L, et al.
Publicado: (2007) -
Efficacy of tiotropium–olodaterol fixed-dose combination in COPD
por: Derom, Eric, et al.
Publicado: (2016) -
Dual bronchodilation with tiotropium/olodaterol further reduces activity-related breathlessness versus tiotropium alone in COPD
por: Maltais, François, et al.
Publicado: (2019)